Old Web
English
Sign In
Acemap
>
authorDetail
>
Cathie Scalzo
Cathie Scalzo
Merck & Co.
Pathology
Oncology
Pembrolizumab
Internal medicine
Medicine
2
Papers
377
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study
2019
Journal of Clinical Oncology
Edward B. Garon
Matthew D. Hellmann
Naiyer A. Rizvi
Enric Carcereny
Natasha B. Leighl
Myung-Ju Ahn
Joseph Paul Eder
Ani Sarkis Balmanoukian
Charu Aggarwal
Leora Horn
Amita Patnaik
Matthew A. Gubens
Suresh S. Ramalingam
Enriqueta Felip
Jonathan W. Goldman
Cathie Scalzo
Erin Jensen
D. Kush
Rina Hui
Show All
Source
Cite
Save
Citations (369)
Five-year long-term overall survival for patients with advanced NSCLC treated with pembrolizumab: Results from KEYNOTE-001.
2019
Journal of Clinical Oncology
Edward B. Garon
Matthew D. Hellmann
Enric Carcereny Costa
Natasha B. Leighl
Myung-Ju Ahn
Joseph Paul Eder
Ani Sarkis Balmanoukian
Charu Aggarwal
Leora Horn
Amita Patnaik
Matthew A. Gubens
Suresh S. Ramalingam
Enriqueta Felip
Cathie Scalzo
Erin Jensen
D. Kush
Rina Hui
Show All
Source
Cite
Save
Citations (8)
1